URL | Priority | Change frequency | Last modified (GMT) |
---|---|---|---|
https://beyondspringpharma.com/beyondspring-announces-35-4-million-sale-of-a-portion-of-equity-interest-in-seed-therapeutics-to-advance-lead-asset-plinabulin-to-anti-cancer-registrational-studies/ | 20% | Monthly | 2025-01-27 21:07 |